Comment Letter
Comments on National Coverage Analysis: Transcatheter Aortic Valve Replacement and Broader CED Policy Considerations
January 14, 2026
Featured Experts: Darius Lakdawalla, PhD, Barry Liden, JD
Research
All Research Featured Research
Comment Letter
Response to the Draft Report of the Health Economics Methods Advisory (HEMA): “Defining Appropriate Benefits for Economic Evaluation of Health Care Technologies”
October 21, 2025
Featured Experts: Alice Chen, PhD, Jason Doctor, PhD, Dana Goldman, PhD, Darius Lakdawalla, PhD, Barry Liden, JD, Karen Mulligan, PhD, Desi Peneva, MS, Charles E. Phelps, PhD
News
Former FDA Leaders Say New Policies Needed to Boost Medical Innovation
September 26, 2025
Featured Experts: Lowell Schiller, JD, Barry Liden, JD
News
Schaeffer Center White Paper Outlines FDA Reforms to Boost Pharmaceutical Innovation and Expand Access
September 11, 2025
Featured Experts: Lowell Schiller, JD, Barry Liden, JD
White Paper
A Blueprint for FDA: Recommendations to Improve Innovation and Access
September 11, 2025
Featured Experts: Lowell Schiller, JD, Barry Liden, JD
Comment Letter
Comments to USTR on Foreign Nations Freeloading on American-Financed Innovation
June 27, 2025
Featured Experts: Dana Goldman, PhD, Darius Lakdawalla, PhD, Barry Liden, JD
Comment Letter
Comments to Representatives DeGette and Bucshon on Building on the Successes of 21st Century Cures
August 8, 2024
Featured Experts: Darius Lakdawalla, PhD, Barry Liden, JD
Evidence Base
A Patient-Focused, Evidence-Driven Approach to PBM Reform
July 22, 2024
Featured Experts: Karen Van Nuys, PhD, Dana Goldman, PhD, Stephanie Hedt, MPP, Geoffrey Joyce, PhD, Darius Lakdawalla, PhD, Barry Liden, JD, Neeraj Sood, PhD, Erin Trish, PhD
Comment Letter
Comments to CMS on Transcatheter Tricuspid Valve Replacement (TTVR) and Broader CED Policy Considerations
July 18, 2024
Featured Experts: Darius Lakdawalla, PhD, Barry Liden, JD
Journal Article
A Roadmap for Improving Medicare’s Application of Coverage With Evidence Development
May 22, 2024
Featured Experts: Darius Lakdawalla, PhD, Barry Liden, JD
Issue Brief
A New Healthcare Valuation Model That Puts Patients First: Generalized Risk Adjusted Cost-Effectiveness (GRACE)
April 23, 2024
Featured Experts: Darius Lakdawalla, PhD, Stephanie Hedt, MPP, Barry Liden, JD
Comment Letter
Response to Sen. Cassidy’s Request for Information on Improving Americans’ Access to Gene Therapies
January 19, 2024
Featured Experts: Darius Lakdawalla, PhD, Joseph Grogan, JD, Stephanie Hedt, MPP, Barry Liden, JD, Erin Trish, PhD, Karen Van Nuys, PhD
Comment Letter
Comments in Response to a CBO Call for New Research on Obesity
November 2, 2023
Featured Experts: Dana Goldman, PhD, Darius Lakdawalla, PhD, Karen Van Nuys, PhD, Alison Sexton Ward, PhD, Bryan Tysinger, PhD, Barry Liden, JD
Comment Letter
Comments to CMS on Proposed Guidance for Coverage with Evidence Development
August 25, 2023
Featured Experts: Alice Chen, PhD, Joseph Grogan, JD, Mireille Jacobson, PhD, Geoffrey Joyce, PhD, Darius Lakdawalla, PhD, Barry Liden, JD, Eugene Lin, MD, MS, Karen Van Nuys, PhD, William Padula, PhD, Alison Sexton Ward, PhD, Julie Zissimopoulos, PhD
Comment Letter
Comments to CMS on the Inflation Reduction Act’s Drug Price Negotiation Program
April 17, 2023
Featured Experts: Dana Goldman, PhD, Charles E. Phelps, PhD, Darius Lakdawalla, PhD, Joseph Grogan, JD, Karen Van Nuys, PhD, Barry Liden, JD, William Padula, PhD
White Paper
Mitigating the Inflation Reduction Act’s Adverse Impacts on the Prescription Drug Market
April 13, 2023
Featured Experts: Dana Goldman, PhD, Joseph Grogan, JD, Darius Lakdawalla, PhD, Barry Liden, JD, Erin Trish, PhD
Comment Letter
Comments on AHRQ Analysis of Requirements for Coverage with Evidence Development
September 28, 2022
Featured Experts: Dana Goldman, PhD, William Padula, PhD, Joseph Grogan, JD, Barry Liden, JD